Search all medical codes

Hormone sensitive malignancy status

ICD10CM code

Medical Policies and Guidelines for Hormone sensitive malignancy status

Related policies from health plans

Gamma Glutamyl Transferase Testing
Outpatient Laboratory-based Blood Glucose Testing
Outpatient Urine Culture
Thyroid Testing
CG-LAB-20 Thyroid Testing
CG-LAB-24 Outpatient Urine Culture
CG-LAB-29 Gamma Glutamyl Transferase Testing
CG-LAB-30 Outpatient Laboratory-based Blood Glucose Testing
Transthoracic Echocardiography in Children - (0523)

Similar Codes


ICD10CM codes

Z19.1 - Hormone sensitive malignancy status
Z19 - Hormone sensitivity malignancy status
Z19.2 - Hormone resistant malignancy status
Z17 - Estrogen receptor status
Z85 - Personal history of malignant neoplasm
Z85.85 - Personal history of malignant neoplasm of endocrine glands
Z85.9 - Personal history of malignant neoplasm, unspecified
Z85.3 - Personal history of malignant neoplasm of breast
Z12.3 - Encounter for screening for malignant neoplasm of breast
Z15.0 - Genetic susceptibility to malignant neoplasm

HCPCS codes

G9842 - Patient has metastatic disease at diagnosis
G9097 - Oncology; disease status; esophageal cancer, limited to adenocarcinoma or squamous cell carcinoma as
G8875 - Clinician diagnosed breast cancer preoperatively by a minimally invasive biopsy method
G9552 - Incidental thyroid nodule < 1.0 cm noted in report
D7430 - Excision of benign tumor-lesion diameter up to 1.25 cm
G8721 - Pt category (primary tumor), pn category (regional lymph nodes), and histologic grade were documente
D0190 - Screening of a patient
G9618 - Documentation of screening for uterine malignancy or those that had an ultrasound and/or endometrial
D0191 - Assessment of a patient
G9549 - Documentation of medical reason(s) that follow-up imaging is indicated (e.g., patient has lymphadeno

CPT4 codes

3374F - AJCC Breast Cancer Stage I: T1c (tumor size > 1 cm to 2 cm) documented (ONC)
3344F - Mammogram assessment category of suspicious, documented (RAD)
3315F - Estrogen receptor (ER) or progesterone receptor (PR) positive breast cancer (ONC)
81500 - Oncology (ovarian), biochemical assays of two proteins (CA-125 and HE4), utilizing serum, with menop
3316F - Estrogen receptor (ER) and progesterone receptor (PR) negative breast cancer (ONC)
3342F - Mammogram assessment category of benign, documented (RAD)
3388F - AJCC colon cancer, Stage III documented (ONC)
58956 - Bilateral salpingo-oophorectomy with total omentectomy, total abdominal hysterectomy for malignancy
0045U - Oncology (breast ductal carcinoma in situ), mRNA, gene expression profiling by real-time RT-PCR of 1
1150F - Documentation that a patient has a substantial risk of death within 1 year (Pall Cr)